Accenture insider plans sale of 5,500 shares

Accenture’s Class A ordinary shares are being prepared for sale under Rule 144 by Julie Sweet.

Accepted by SEC EDGAR 02/03/2026 - 04:01 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Accenture’s Class A ordinary shares are being prepared for sale under Rule 144 by Julie Sweet. The notice covers 5,500 Class A ordinary shares, to be sold through UBS Financial Services Inc. on the NYSE, with an aggregate market value listed as 1,371,920.00. These shares were acquired as a stock award from the issuer on 02/01/2026.

The filing also discloses prior sales by Julie Sweet over the past three months: 5,917 Class A ordinary shares sold on 11/05/2025 for gross proceeds of 1,459,276.57, and 1,694 shares sold on 01/14/2026 for 488,380.20. Shares outstanding are reported as 660,432,542 Class A ordinary shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ACN disclose about Julie Sweet’s planned sale?

The Form 144 shows Julie Sweet plans to sell 5,500 Class A ordinary shares of Accenture through UBS Financial Services Inc. on the NYSE. The filing lists an aggregate market value of 1,371,920.00 for these shares.

How were the 5,500 Accenture (ACN) shares being sold by Julie Sweet acquired?

The 5,500 Class A ordinary shares were acquired on 02/01/2026 as a stock award from the issuer. The filing notes the acquisition date and states the nature of the transaction as a stock award rather than an open-market purchase.

What recent Accenture (ACN) share sales by Julie Sweet are disclosed in the Form 144?

The filing lists prior sales over three months: 5,917 Class A ordinary shares sold on 11/05/2025 for 1,459,276.57, and 1,694 shares sold on 01/14/2026 for 488,380.20. These amounts represent recent dispositions of Accenture stock.

How many Accenture (ACN) Class A shares are outstanding according to this notice?

The Form 144 reports 660,432,542 Class A ordinary shares outstanding. This figure provides context for the 5,500-share planned sale, giving investors a sense of the company’s total equity base relative to the disclosed transaction.

Which broker and exchange are involved in Julie Sweet’s planned Accenture (ACN) share sale?

The filing identifies UBS Financial Services Inc., located at 11 Madison Avenue, New York, as the broker. The planned sale of 5,500 Class A ordinary shares is stated to occur on the NYSE, specifying the intended trading venue.

What is the approximate date of sale for the 5,500 Accenture (ACN) shares in the Form 144?

The Form 144 lists an approximate sale date of 02/03/2026 for the 5,500 Class A ordinary shares. This date indicates when the filer expects to begin selling the shares, subject to market conditions and Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001487630
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Accenture plc
SEC File Number	001-34448
Address of Issuer	1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN IRELAND D2
Phone	353-1-646-2000
Name of Person for Whose Account the Securities are To Be Sold	Sweet Julie Spellman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	5500	1371920.00	660432542	02/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	02/01/2026	Stock Award	Issuer			5500	02/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Julie Sweet 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN L2 D2	Class A Ordinary	11/05/2025	5917	1459276.57
Julie Sweet 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR Dublin L2 L2	Class A Ordinary	01/14/2026	1694	488380.20

144: Remarks and Signature

Remarks
Date of Notice	02/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Julie Sweet
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)